Menu Search
Equities

Predictive Oncology Inc

S1K:MUN

Predictive Oncology Inc

Actions
  • Price (EUR)0.745
  • Today's Change0.00 / 0.00%
  • Shares traded200.00
  • 1 Year change-75.65%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 07:01 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Predictive Oncology Inc grew revenues 18.24% from 1.51m to 1.78m while net income improved from a loss of 25.74m to a smaller loss of 13.98m.
Gross margin60.23%
Net profit margin-802.93%
Operating margin-805.63%
Return on assets-88.98%
Return on equity-149.37%
Return on investment-121.17%
More ▼

Cash flow in USDView more

In 2023, cash reserves at Predictive Oncology Inc fell by 13.34m. Cash Flow from Financing totalled 148.90k or 8.36% of revenues. In addition the company used 13.19m for operations while cash used for investing totalled 302.37k.
Cash flow per share-3.18
Price/Cash flow per share--
Book value per share0.7171
Tangible book value per share0.6753
More ▼

Balance sheet in USDView more

Predictive Oncology Inc appears to have little financial risk as the company holds a substantial amount of cash on its books. In fact, 1.60% of the market capitalization can be attributed to its 8.73m and debt could be paid in full if management chose.
Current ratio1.49
Quick ratio1.37
Total debt/total equity0.0676
Total debt/total capital0.0634
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.